Healing Circles: An Intervention for Canadian Indigenous Mothers & Children Affected by IPV

March 13, 2024 updated by: Caroline Piotrowski, University of Manitoba

Healing Circles: An Evaluation of an Intervention for Canadian Indigenous Mothers and Children Affected by Intimate Partner Violence

Evaluation of Mother's Empowerment Program and Kid's Club Program adapted specifically for Indigenous mothers and children affected by intimate partner violence in Canada

Study Overview

Detailed Description

Research Goals & Objectives. Our overall goal is to conduct a feasibility study of two successful evidence-based interventions (Mother's Empowerment Program and Kid's Club Program) designed specifically to meet the needs of Indigenous mothers and their children who have experienced intimate partner violence (IPV).

Specifically, our objectives are:

  1. To successfully adapt two existing effective evidence-based interventions for mothers and children who have experienced IPV for Indigenous mothers and children who have experienced IPV. Our adaptation process reflects our overall integrated knowledge translation (iKT) approach, undertaken in close partnership with our Community Advisory Council (CAC) and in consultation with Elders at both sites. As outlined by the Canadian Institutes of Health Research (CIHR), it follows a two-eyed seeing approach, incorporating Western and Indigenous knowledge, ways of knowing and being.
  2. To pilot and evaluate our adapted interventions with mothers and children recruited from our community partners (Wahbung Abinoonjiiag, an Indigenous non-profit organization in Winnipeg and Discovery House, a crisis shelter and second stage housing facility for women in Calgary). We plan to evaluate our adapted programs using a two-eyed seeing approach that combines Western (quantitative) and Indigenous (qualitative) methodologies. As part of our iKT approach, our mixed methods evaluation will rely upon ongoing engagement and feedback from our CAC. Quantitative methods (e.g., standardized questionnaires) will be used to assess changes in the mental and physical health and well-being of mothers and their children over time. Qualitative methods (e.g., semi-structured interviews, narratives) will be used to evaluate the intervention experience and perceived changes in self perceptions (e.g., resilience).

Hypotheses. We will determine if there is an increase, both immediately post-intervention and sustained over 6-8 months, in mothers' and children's mental (e.g., resilience) and physical well-being (e.g., perceived health status), and if there is a reduction in mothers' and children's mental health (e.g., depression, anxiety and traumatic stress symptoms) and physical difficulties (e.g., somatic symptoms such as headaches). For children, analyses will take age, gender and sex into account.

Study Type

Interventional

Enrollment (Estimated)

160

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

  • Name: Nicole Letourneau, PhD RN
  • Phone Number: 1-800-555-5555

Study Locations

    • Alberta
      • Calgary, Alberta, Canada, T2A 7R7

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

4 years to 11 years (Child)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • mothers self-reported experience of past intimate partner violence, English-speaking, with at least one school-aged child

Exclusion Criteria:

-

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: Wait List Control
Participants receive intervention after 12 week delay
Weekly groups administered to mothers and children simultaneously but separately for 10 weeks

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Maternal Depression
Time Frame: Measured immediately post-intervention
Centers for Epidemiological Studies-Depression (CES-D)
Measured immediately post-intervention
Maternal Depression
Time Frame: Measured 6-8 months post-intervention
Centers for Epidemiological Studies-Depression (CES-D)
Measured 6-8 months post-intervention
Child Depression
Time Frame: Measured Immediately post-intervention
Child Depression Inventory (CDI)
Measured Immediately post-intervention
Child Depression
Time Frame: Measured 6-8 months post-intervention
Child Depression Inventory (CDI)
Measured 6-8 months post-intervention
Maternal Anxiety
Time Frame: Measured Immediately post-intervention
Beck Anxiety Scale
Measured Immediately post-intervention
Maternal Anxiety
Time Frame: Measured 6-8 months post-intervention
Beck Anxiety Scale
Measured 6-8 months post-intervention
Child Anxiety
Time Frame: Measured immediately post-intervention
Revised Children's Manifest Anxiety Scale - 2nd Edition Short Form (RCMAS-2)
Measured immediately post-intervention
Child Anxiety
Time Frame: Measured 6-8 months post-intervention
Revised Children's Manifest Anxiety Scale - 2nd Edition Short Form (RCMAS-2)
Measured 6-8 months post-intervention
Maternal trauma symptoms
Time Frame: Measured immediately post-intervention
PTSD Checklist (PCL-5)
Measured immediately post-intervention
Maternal trauma symptoms
Time Frame: Measured 6-8 months post-intervention
PTSD Checklist (PCL-5)
Measured 6-8 months post-intervention
Child trauma symptoms
Time Frame: Measured immediately post-intervention
University of California - Los Angeles (UCLA) Reaction Index
Measured immediately post-intervention
Child trauma symptoms
Time Frame: Measured 6-8 months post-intervention
University of California - Los Angeles (UCLA) Reaction Index
Measured 6-8 months post-intervention

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Maternal resilience
Time Frame: Measured immediately post-intervention
Adult Resilience Measure - revised (ARM-R)
Measured immediately post-intervention
Maternal resilience
Time Frame: Measured 6-8 months post-intervention
Adult Resilience Measure - revised (ARM-R)
Measured 6-8 months post-intervention
Child resilience
Time Frame: Measured immediately post-intervention
Child & Youth Resilience Measure - revised (CYRM-R)
Measured immediately post-intervention
Child resilience
Time Frame: Measured 6-8 months post-intervention
Child & Youth Resilience Measure - revised (CYRM-R)
Measured 6-8 months post-intervention
Maternal social support
Time Frame: Measured immediately post-intervention
Inventory of Socially Supportive Behaviors
Measured immediately post-intervention
Maternal social support
Time Frame: Measured 6-8 months post-intervention
Inventory of Socially Supportive Behaviors
Measured 6-8 months post-intervention
Maternal self esteem
Time Frame: Measured immediately post-intervention
Rosenberg Self Esteem Scale
Measured immediately post-intervention
Maternal self esteem
Time Frame: Measured 6-8 months post-intervention
Rosenberg Self Esteem Scale
Measured 6-8 months post-intervention

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Caroline Piotrowski, PhD MPH, University of Manitoba

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 23, 2024

Primary Completion (Estimated)

December 30, 2025

Study Completion (Estimated)

July 30, 2026

Study Registration Dates

First Submitted

January 15, 2020

First Submitted That Met QC Criteria

January 16, 2020

First Posted (Actual)

January 21, 2020

Study Record Updates

Last Update Posted (Actual)

March 15, 2024

Last Update Submitted That Met QC Criteria

March 13, 2024

Last Verified

March 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • H2019:501

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Violence, Domestic

3
Subscribe